This site is intended for health professionals only
Tuesday 18 December 2018
LatestNews
Share |

Latest News

European Commission approval for self-administration of Xolair® across all indications

Monday 17th December 2018
Novartis has announced that the European Commission (EC) has approved Xolair® (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU) to administer their own treatment.
 
With this approval, Xolair is the first and only biologic to offer the option of self-administration for SAA and CSU.
 
Xolair,...
Tue, 13 Nov 2018
Excess fat causes the body’s cancer-fighting “natural killer cells” to fail, explaining the link between obesity and cancer, researchers have said.
Thu, 8 Nov 2018
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ratio of daunorubicin and cytarabine
Fri, 2 Nov 2018
There should be vegetarian and vegan alternatives to medicines such as vaccines, a charity has said.